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Background

Results

Discussion

Stroke readmissions represent a significant source of morbidity, mortality and healthcare
spending. According to statistics from the Centers of Disease Control and Prevention
(CDC), someone suffers a stroke every 40 seconds in the United States, and
approximately 795,000 individual events occur annually.1 All-cause readmissions
account for $26 billion in healthcare spending per year, which prompted creation of the
Medicare Hospital Readmission Reduction Program as a component of the Affordable
Care Act in 2012. This legislation standardized the 30-day window after discharge as a
target for readmission improvement.2

Preliminary analysis included 208 individuals (95 in-person, 113 telemedicine). Our
results showed that among these patients, 12 (5.8%) experienced all-cause readmissions
within 30 days of hospital discharge. Of the 12 patients readmitted, 2 were seen in-person
(2.1%) and 10 were seen via telemedicine (8.8%). Chi Square revealed a between group
difference (X2 = 4.318, p = 0.038).

TOC clinic has been shown to be efficacious for reducing 30-day readmissions for
numerous chronic conditions. However, there is a dearth of literature reflecting its utility
with stroke. Our initial results are extremely encouraging when comparing our derived
30-day readmission rates with those reported in previous publications. Our combined
figure (5.8%) as well as individual telemedicine (8.8%) and in-person (2.1%)
readmission numbers outperform those most recently published by the CMS (11.8%)
from 2015-16 (see graph).7
The difference between in-person and telemedicine TOC readmission statistics might be
explained by numerous different factors. Telemedicine data was predominantly collected
during the height of the coronavirus pandemic. Patients may have been experiencing
worse overall health due to limited access to medical care, isolation and fewer
opportunities for exercise. Because telemedicine clinic can be conducted from home, it
may capture patients who would forego in-person clinic due to various personal barriers
(apathy, time, transportation). These patients may also be less adherent to their treatment
regimens. Navigating novel technology is challenging for many individuals. The added
complexity of using a virtual platform may detract from the ability to absorb information
and result in poorer adherence to therapies. Further research into perceived barriers
should be conducted.

Previous literature utilizing the Nationwide Readmissions Database showed that between
11.98 – 13.47% of stroke patients are readmitted within 30 days of discharge.3 A separate
study considering Medicare fee-for-service records found a 14.4% readmission rate
among the publicly insured.4
Transitions of care (TOC) is a means of providing continuity from one setting or level of
care to another through strategic counselling. Previous studies have shown that TOC
clinic follow-up visits are an effective means of reducing all-cause readmissions for a
variety of chronic conditions including congestive heart failure, asthma, diabetes and
depression.5 A previous study looking specifically at 30-day stroke readmissions among
the Medicare fee-for-service population showed a slight improvement in the hazard ratio
when employing TOC clinic with either a neurologist or primary care physician.6

We have ascertained evidence for two of our aims (1 & 3) thus far. We are awaiting
queries from TJUH data managers to explore aim 2. More samples incorporating
confidence measures are currently being collected to allow us to perform a meaningful
analysis for aim 4.

Study goals:
v Aim 1: Examine if there is a difference between 30-day stroke readmission rate when
employing TOC clinic and the reported national average.
v Aim 2: Examine if there is a difference between 30-day stroke readmission rate when
employing TOC clinic and the TJUH average with TOC patients removed.
v Aim 3: Determine if in-patient TOC clinic and telemedicine TOC clinic elicit
different results in terms of 30-day stroke readmission rate at TJUH.
v Aim 4: Examine patient reported survey measures (self-efficacy, confidence,
perceived TOC value) to guide improvements.

Limitations & Future Directions

Methods
Our study seeks to build on previous literature by exploring the efficacy of TOC clinic for
reducing stroke readmission at Thomas Jefferson University Hospital (TJUH), a certified
comprehensive stroke center in Philadelphia. We are utilizing a prospective cohort study
design. Potential participants were identified at TJUH beginning in January of 2019 by
ICD-10 codes corresponding with various ischemic and hemorrhagic stroke diagnoses.
Patients were initially automatically scheduled for an in-clinic TOC appointment with a
vascular neurologist or clinical nurse practitioner within 1 to 3 weeks of hospital discharge.
When coronavirus precautions were implemented at TJUH in February of 2021, these visits
were transitioned to telemedicine appointments.

Participants in both the in-person group (u = 8.421, SD = 1.835) and telemedicine group
(u = 8.100, SD = 1.875) considered TOC a valuable experience. Analysis of perceived
TOC value did not differ between groups (t = 0.654, p = 0.515). Measures of patient
confidence (before TOC clinic versus after) are still being conducted and will be
analyzed using a paired samples t-test.

Goals of these visits:
v Clarify diagnosis and treatment plan
v Improve medication adherence by reinforcing appropriate use
v Assuage fears from discharge
Telephone follow-up surveys are administered to TOC participants within 6 months of their
visit. These questionnaires employ measures of self-efficacy, confidence and perceived
value of TOC clinic. Individual survey items were assessed for validity by all team
members prior to clinical implementation. 30-day readmission rates are collected from
individual patient electronic health records. All patient data is collected and stored in a
password-protected living document that can only be accessed by the three team members
actively recording data for the project. Data analysis is being conducted on a Macintosh
computer (OS 10.15.5) using IBM SPSS (version 27).

Measures of patient confidence (before TOC clinic versus after) were added to the survey
in December of 2020 and are still being collected. When a sufficient sample size has been
achieved, we will analyze this using a paired samples t-test. An annual TJUH 30-day stroke
readmission dataset is being prepared with TOC patients removed to enable internal
comparison. When preparation is complete, we will compare our final TOC figures to
TJUH standard of care home discharge rates as well as a nationally representative sample
based on the most recently published Medicare/Medicaid stroke readmission data from the
Centers of Medicare and Medicaid Services (CMS). This analysis will be performed using
one sample z-test in excel.

Limitations:
v Telemedicine TOC was not initially a component of the project charter, thus the
sample size when considering each group individually is smaller than intended
v Patients may experience recall bias when answering telephone survey questions
v Nationally representative figures have not been updated annually and may not reflect
current trends
Future Directions:
v Translate findings into practical institutional policy
v Perform qualitative study of perceived barriers to telemedicine stroke clinic to make
platform more accessible
v Repeat study parameters in post-covid era to determine if pandemic confounded
findings
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